Victorian Infectious Diseases Reference Laboratory

2001

Hepatitis C: all about the virus

Aitken C, Bowden S, Crofts N, MacDonald M, Sievert W. 2001.
National Hepatitis C Resource Manual. Commonwealth Department of Health and Aged Care, Canberra.

Reducing hepatitis C transmission in the community

Aitken C, Boyce N, S. Carruthers, R. Chen, N. Crofts, S. Locarnini, S. Loveday, A. MacKintosh, M. McDonald, A. Ridge, D. Sansom, T. Speed, and J.Woodruff. 2001.
National Hepatitis C Resource Manual. Commonwealth Department of Health and Aged Care, Canberra.

Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotype.

Bartholomeusz A, and Locarnini S. 2001.
Hepatology 34:432-435.

Treatments for Hepatitis C

Batey R, Chen R, Lee J-Y, Locarnini S, McCoy R, Richmond J, Sievert W, and Sasadeusz J. 2001.
National Hepatitis C Resource Manual. Commonwealth Department of Health and Aged Care, Canberra.

Simultaneous isolation of verotoxin-producing strains of Escherichia coli O128:H2 and viruses in gastroenteritis outbreaks.

Bettelheim K A, Bennett-Wood V, Lightfoot D, Wright PJ, and Marshall JA. 2001.
Comp Immunol Microbiol Infect Dis 24:135-142.

The use of the laboratory in the diagnosis and management of HIV infection.

Birch C, and Dwyer D. 2001.
Isis Medical Media Ltd, Oxford.

Structural organization of the hepatitis B virus minichromosome.

Bock CT, Schwinn S, Locarnini S, Fyfe J, Manns MP, Trautwein C, and Zentgraf H. 2001.
J Mol Biol 307: 183-196.

Laboratory diagnosis of the hepatitis C virus infection

Bowden S. 2001.
In N. Crofts, G. Dore, and S. Locarnini (ed.), Hepatitis C: An Australian Perspective. IP Communications, Melbourne, Australia.

New hepatitis viruses: Contenders and pretenders.

Bowden S. 2001.
J Gastro Hepatol 16:124-131.

Hepatitis C testing

Bowden S, Conrad S, Harley H, Harvey P, McCaw R, Mitchell J, and Wallace J. 2001.
National Hepatitis C Resource Manual. Commonwealth Department of Health and Aged Care, Canberra.

Hepatitis C, other hepatitis viruses and HIV

Bowden S, Crofts N, McCoy R, Mudge L and Sievert W. 2001.
National Hepatitis C Resource Manual. Commonwealth Department of Health and Aged Care, Canberra.

HIV testing in Australia

Breschkin A, Birch C, and Catton M. 2001.
In R. Dunstan (ed.), Abnormal Laboratory Results. McGraw Hill Book Company, Sydney.

Influenza vaccine for healthy working adults.

Byrnes GB, and Kelly H. 2001.
JAMA 285:290-291.

Transmission of HCV in the Vietnamese community.

Caruana S, Bowden S, and Kelly H. 2001.
Aust N Z J Public Health 25:276.

Laboratory diagnosis of HIV infection in Australia.

Catton M. 2001.
Microbiol Aust 22:17-18.

Coxsackie virus A24 infection presenting as acute flaccid paralysis.

Chaves SS, Lobo S, Kennett M, and Black J. 2001.
Lancet 357:605.

In vitro susceptibilities of wildtype or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methylbeta- L-arabinofuranosyluracil.

Chin R, Shaw T, Torresi J, Sozzi V, Trautwein C, Bock CT, Manns M, Isom H, Furman P, and Locarnini S. 2001.
Antimicrob Agents Chemother 45:2495-2501.

Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection.

Colonno RJ, Genovesi EV, Medina I, Lamb L, Durham SK, Huang ML, Corey L, Littlejohn M, Locarnini S, Tennant BC, Rose B, and Clark JM. 2001.
J Infect Dis 184:1236-1245.

Capnocytophaga canimorsus: A serious infection masquerading as a serious infection.

Cooley L. 2001.
Victorian Infectious Diseases Bulletin 4:37-38.

Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.

Delaney WE, Locarnini S, and Shaw T. 2001.
Antivir Chem Chemother 12:1-35.

Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drugresistant strains of hepatitis B virus.

Delaney WE, Edwards R, Colledge D, Shaw T, Torresi J, Miller TG, Isom HC, Bock CT, Manns MP, Trautwein C, and Locarnini S. 2001.
Antimicrob Agents Chemother 45:1705-1713.

Survival of hepatitis C surrogate in anaesthetic and analgesic drugs.

Druce J, Catton M, Ryan G, and Birch C. 2001.
Australian Infection Control 6:89-90.

Human Immunodeficiency virus: disinfection and control.

Druce J. 2001.
In: Block S, editor. Disinfection, sterilization and preservation. 5th ed. Philadelphia: Lippincott,Williams and Wilkins, 573-584.

Studies in progress: Acute flaccid paralysis.

D'Souza R, Kennett M, Kelly H, Brussen K, Antony J, Longbottom, Elliot E, and Morris M. 2001.
Eighth Annual Report, Australian Paediatric Surveillance Unit.

Antiretroviral drug resistance.

Dwyer D, Birch C, and Saskena N. 2001.
Microbiol Aust 22:28-31.

The impact of diagnosis by legionella urinary antigen test on the epidemiology and outcomes of Legionnaires' disease.

Formica N, Yates M, Beers M, Carnie J, Hogg G, Ryan N, and Tallis G. 2001.
Epidemiol Infect 127:275-280.

Genus Rubivirus.

Gillam S, and Lee J-Y. 2001.
In C. Tidona and G. Darai (ed.), The Springer Index of Viruses. Springer Verlag, Heidelberg.

Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.

Gorry PR, Bristol G, Zack JA, Ritola K, Swanstrom R, Birch CJ, Bell JE, Bannert N, Crawford K, Wang H, Schols D, De Clercq E, Kunstman K, Wolinsky SM, and Gabuzda D. 2001.
J Virol 75:10073-10089.

Predictive value of personal recall of chicken pox infection: implications for the use of varicella vaccine.

Karunajeewa H, and Kelly HA. 2001.
Med J Aust 174:153.

Seroprevalence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management.

Karunajeewa H, Siebert D, Hammond R, Garland S, and Kelly H. 2001.
Aust N Z J Obstet Gynaecol 41:23-28.

A diphtheria-tetanus-acellular pertussis vaccine for adults: the wrong booster vaccine for Australia?

Kelly HA, and Andrews RM. 2001.
Med J Aust 175:173-174.

Laboratory containment of wild poliovirus.

Kelly H, Prasopa-Plaizier N, and Ballard S. 2001.
JAMA 286:536.

Acute flaccid paralysis surveillance in Australia.

Kelly H, Brussen K, Morris A, and Elliot E. 2001.
WHO Bulletin 79:1169-1170.

Measles immunity among young adults

Kelly HA, Riddell MA, Lambert SB, Leydon JA, and Catton MG. 2001.
Victoria. Commun Dis Intell 25:129-132.

Measles surveillance: how many hospital cases are we missing?

Lawrence G, Lambert S, Kelly H, and Andrews R. 2001.
Comm Dis Intell 25:137-141.

Duck hepatitis B virus replication in primary bile duct epithelial cells.

Lee JY, Culvenor JG, Angus P, Smallwood R, Nicoll A, and Locarnini S. 2001.
J Virol 75:7651-7661.

Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed.

Lewin SR, Ribeiro RM, Walters T, Lau GK, Bowden S, Locarnini S, and Perelson AS. 2001.
Hepatology 34:1012-1020.

Comparison of a multiplex reverse transcription-pcr enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens.

Liolios L, Jenney A, Spelman D, Kotsimbos T, Catton M, and Wesselingh S. 2001.
J Clin Microbiol 39:2779-2783.

High level excretion of Norwalk-like virus following resolution of clinical illness.

Marshall JA, Salamone S, Yuen L, Catton MG, and Wright JP. 2001.
Pathology 33:50-52.

Multiple outbreaks of Norwalklike virus gastro-enteritis associated with a Mediterranean-style restaurant.

Marshall JA, Yuen LK, Catton MG, Gunesekere IC, Wright PJ, Bettelheim KA, Griffith JM, Lightfoot D, Hogg GG, Gregory J, Wilby R, and Gaston J. 2001.
J Med Microbiol 50:143- 151.

Diagnosis of enteric pathogens in children with gastroenteritis.

McIver CJ, Hansman G, White P, Doultree JC, Catton M, and Rawlinson WD. 2001.
Pathology 33:353-358.

Baseline antiretroviral drug susceptibility influences treatment response in patients receiving saquinavirenhancing therapy.

Middleton T, Smith T, Larder B, Law M, and Birch C. 2001.
HIV Clin Trials 2:445-52.

Acute flaccid paralysis associated with circulating vaccine-derived poliovirus-Philippines.

National Epidemiology Center, Manilla, Polio Reference Laboratory, VIDRL, and et. al. 2001.
Morbidity and Mortality Weekly Research 50:874- 875.

Hepatitis B Testing

Nicholson S, and Gust I. 2001.
In R. Dunstan (ed.), Abnormal Laboratory Results. McGraw-Hill Book Company, Sydney.

Sequential transmission of Norwalk virus at a holiday camp.

O'Donnell H, O'Grady K, and Marshall JA. 2001.
Victorian Infectious Diseases Bulletin 4:22-24.

DNA fingerprinting analysis of Australian Mycobacterium tuberculosis strains using Gelcompar.

Purcell M, Yuen L, Raios K, Fyfe J, Sievers A, and Hogg G. 2001.
Victorian Infectious Diseases Bulletin 4:20-22.

Uptake of HIV and latex particles by fresh and cultured dendritic cells and monocytes.

Reece JC, Vardaxis NJ, Marshall JA, Crowe SM, and Cameron PU. 2001.
Immunol Cell Biol 79:255-263.

Optimal specimen type and sampling time for recovery of measles virus RNA.

Riddell MA, and Chibo D. 2001.
Victorian Infectious Diseases Bulletin 4:7-8.

A serosurvey evaluation of the school based measles “catch-up” immunisation campaign in Victorian school aged children.

Riddell M, Leydon J, Ugoni A, and Kelly H. 2001.
Aust NZ J Public Health 25:529-533.

Investigation of optimal specimen type and sampling time for detection of measles virus RNA during a measles epidemic.

Riddell MA, Chibo D, Kelly HA, Catton MG, and Birch CJ. 2001.
J Clin Microbiol 39:375-376.

Imported malaria treated in Melbourne, Australia: epidemiology and clinical features in 246 patients.

Robinson P, Jenney AW, Tachado M, Yung A, Manitta J, Taylor K, and Biggs BA. 2001.
J Travel Med 8:76-81.

Abnormal cervical cytology in bone marrow transplant recipients.

Sasadeusz J, Kelly H, Szer J, Schwarer AP, Mitchell H, and Grigg A. 2001.
Bone Marrow Transplant 28:393-397.

A member of the delta subgroup of proteobacteria from a pyogenic liver abscess is a typical sulfate reducer of the genus Desulfovibrio.

Schoenborn L, Abdollahi H, Tee W, Dyall-Smith M, and Janssen PH. 2001.
J Clin Microbiol 39:787-90.

Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.

Shehu-Xhilaga M, Kraeusslich HG, Pettit S, Swanstrom R, Lee JY, Marshall JA, Crowe SM, and Mak J. 2001.
J Virol 75:9156-9164.

Hepatitis B: issues in laboratory diagnosis and vaccination

Siebert D, and Locarnini S. 2001.
In R. Dunstan (ed.), Abnormal Laboratory Results. McGraw-Hill Book Company, Sydney.

Hepatitis C: diagnosis and monitoring

Siebert D, Breschkin A, Bowden S, and Locarnini S. 2001.
In R. Dunstan (ed.), Abnormal Laboratory Results. McGraw-Hill Book Company, Sydney.

The Mycobacterium Reference Laboratory: Activities for 2000.Sievers A, and Fyfe J. 2001.
Victorian Infectious Diseases Bulletin 4:38-39.

Healthcare workers continue to be at risk of measles: a case for better vaccination coverage (letter).

Skull S, Andrews RA, Gorrie G, Riddell MA, and Street A. 2001.
Med J Aust 174:662-663.

Monocytes harbour replicationcompetent, non-latent HIV-1 in patients on highly active antiretroviral therapy.

Sonza S, Mutimer HP, Oelrichs R, Jardine D, Harvey K, Dunne A, Purcell DF, Birch C, and Crowe SM. 2001.
AIDS 15:17-22.

Report of the Australian National Polio Reference Laboratory, 1 July to 31 December 2000.

Stambos V, Brussen KA, Turnbull A, Thorley B, and Kennett M. 2001.
Commun Dis Intell 25:54-58.

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region.

Stuyver LJ, Locarnini, Lok A, Richman DD, Carman WF, Dienstag JL, and Schinazi RF. 2001.
Hepatology 33:751-757.

Bacteremia caused by a Helicobacter pullorumlike organism.

Tee W, Montgomery J, and Dyall-Smith M. 2001.
Clin Infect Dis 33:1789-91.

Bacteremia due to “Leptotrichia trevisanii” sp. nov.

Tee W, Midolo P, Janssen PH, Kerr T, and Dyall-Smith ML. 2001.
Eur J Clin Microbiol Infect Dis 20:765-9.

Helicobacter rappini isolates from 2 homosexual men.

Tee W, Jenney A, McPhee A, Mijch A, and Dyall-Smith M. 2001.
Clin Infect Dis 33:8-11.

Virology and molecular virology of the hepatitis C virus

Thompson P, and Locarnini S. 2001.
In N. Crofts, S. Locarnini, and G. Dore (ed.), Hepatitis C: An Australian Perspective. IP Communications, Melbourne, Australia.

Viral hepatitis: antiviral therapy

Torresi J, and Locarnini S. 2001.
In I. Arias, J. Boyer, F. Chisari, N. Fausto, D. Schachter, and D. Shafritz (ed.), The Liver Biology and Pathobiology, 4th ed. Lippincott Williams & Wilkins, Philadelphia.

Investigation of potential iatrogenic transmission of hepatitis C in Victoria, Australia.

Trasancos CC, Kainer MA, Desmond PV, and Kelly H. 2001.
Aust N Z J Public Health 25:241-244.

Heminested multiplex reverse transcription-PCR for detection and differentiation of Norwalk-like virus genogroups 1 and 2 in fecal samples.

Yuen LK, Catton MG, Cox BJ, Wright PJ, and Marshall JA. 2001.
J Clin Microbiol 39:2690-2694.